After transfer, in addition to the direct cellular-mediated cytotoxicity to tumour cells, allogeneic CD8 + CD56+ NKT cells also provide mismatched donor HLA peptide for alloimmune T cell activation in recipients through the allorecognition pathway. Here, CD8A is linked to neoplasm.